7nuk: Difference between revisions
From Proteopedia
Jump to navigationJump to search
New page: '''Unreleased structure''' The entry 7nuk is ON HOLD until Paper Publication Authors: Oerlemans, R., Eris, D., Wang, M., Sharpe, M., Domling, A., Groves, M.R. Description: Crystal stru... |
No edit summary |
||
| (4 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Crystal structure of SARS CoV2 main protease in complex with EG009 (modelled using PanDDA event map)== | |||
<StructureSection load='7nuk' size='340' side='right'caption='[[7nuk]], [[Resolution|resolution]] 2.19Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7NUK OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7NUK FirstGlance]. <br> | |||
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.19Å</td></tr> | |||
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=USH:2-[2-chloranylethanoyl(propyl)amino]-~{N}-(2-methoxyphenyl)ethanamide'>USH</scene></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7nuk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7nuk OCA], [https://pdbe.org/7nuk PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7nuk RCSB], [https://www.ebi.ac.uk/pdbsum/7nuk PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7nuk ProSAT]</span></td></tr> | |||
</table> | |||
<div style="background-color:#fffaf0;"> | |||
== Publication Abstract from PubMed == | |||
Protein-ligand crystallography is widely used to drive advanced stages of drug optimization or to generate starting points for medicinal chemistry by fragment soaking. However, recent progress in protein crystallography could allow for a more integrated role of protein crystallography into the early drug discovery cycle. Here we demonstrate for the first time the interplay of high throughput synthesis and high throughput crystallography. For this we describe a practical multicomponent reaction approach to high diversity acrylamides and esters from diverse building blocks. Surprisingly, in the majority of acrylamides precipitation during the reaction was observed, making library synthesis on a mmol scale and a 96-well format particularly comfortable. The synthesis is also suitable for a high throughput nanoscale format in a highly automated fashion. Moreover, we exemplified the synthesis on a multigram scale featuring good yield and simple work-up. High throughput crystallography of our libraires yielded potent covalent inhibitors of the main protease of the COVID-19 causing agent SARS-CoV-2 in a time efficient manner. Our results demonstrate, that the marriage of in situ HT synthesis of (covalent) libraires and HT crystallography has the potential to accelerate hit finding and to provide meaningful strategies for medicinal chemistry projects. | |||
Marriage of high throughput synthesis and high throughput protein crystallography.,Doemling A, Sutanto F, Shaabani S, Oerlemans R, Deniz E, Patil P, Hadian M, Wang M, Sharpe ME, Groves MR Angew Chem Int Ed Engl. 2021 Jun 7. doi: 10.1002/anie.202105584. PMID:34097796<ref>PMID:34097796</ref> | |||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |||
[[Category: | </div> | ||
[[Category: | <div class="pdbe-citations 7nuk" style="background-color:#fffaf0;"></div> | ||
[[Category: | == References == | ||
[[Category: | <references/> | ||
[[Category: | __TOC__ | ||
[[Category: | </StructureSection> | ||
[[Category: | [[Category: Large Structures]] | ||
[[Category: Domling A]] | |||
[[Category: Eris D]] | |||
[[Category: Groves MR]] | |||
[[Category: Oerlemans R]] | |||
[[Category: Sharpe M]] | |||
[[Category: Wang M]] | |||
Latest revision as of 13:47, 6 November 2024
Crystal structure of SARS CoV2 main protease in complex with EG009 (modelled using PanDDA event map)
| ||||||||||||
